Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Histologic Healing in IBD: Comparison of "Standard" Scores With Expression of Claudin 2 and Impact on Outcomes

NCT07710287 is registered in ClinicalTrials.gov with IRCCS Policlinico S. Donato as lead sponsor.

NCT NCT07710287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07710287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Histologic Healing in IBD: Comparison of "Standard" Scores With Expression of Claudin 2 and Impact on Outcomes
Lead sponsor
IRCCS Policlinico S. Donato
Phase
Observational
Overall status
Recruiting
Start date
February 14, 2025
Completion date
September 30, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, ulcerative colitis (uc)